関節痛注射の市場規模、シェア、成長分析、タイプ別、関節別、最終用途別、地域別 - 産業別予測、2024～2031年

関節痛注射の世界市場規模は、2022年に63億米ドルと評価され、2023年の67億9,000万米ドルから2031年には122億8,000万米ドルに成長し、予測期間（2024-2031年）のCAGRは7.7％で成長する見通しです。

世界の関節痛注射市場は、関節障害の罹患率の上昇、高齢化、低侵襲治療に対する需要の高まりに後押しされ、大幅な成長が見込まれています。これらの注射は、標的の痛みを和らげるだけでなく、関節の機能性を高め、手術に代わる望ましい選択肢となります。有効性と寿命の向上を目指した注射技術や新規製剤の革新が、市場の拡大をさらに後押ししています。再生医療や生物学的注射療法が受け入れられつつあることも、市場力学を変化させています。とはいえ、高コスト、限られた償還オプション、潜在的な副作用といった課題が、将来の成長見通しを阻害する可能性もあります。全体として、この分野は、進化する患者のニーズと技術の進歩によって大きなビジネスチャンスをもたらしています。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次データと一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の見通し
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と見通し

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーターの分析

主な市場の考察

• 重要成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 市場の魅力指数（2023年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析

関節痛注射市場規模：タイプ別

• 市場概要
• ヒアルロン酸注射
• コルチコステロイド注射
• 多血小板血漿注射
• その他

関節痛注射市場規模：関節別

• 市場概要
• 膝
• 肩と肘
• 足首とヒップ
• その他の関節タイプ

関節痛注射市場規模：最終用途別

• 市場概要
• 病院
• クリニック
• その他

関節痛注射市場規模：地域別

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2023年）
• 主な市場企業が採用した戦略
• 市場の最近の動向
• 企業の市場シェア分析（2023年）
• 主要企業の企業プロファイル
  • 会社概要
  • 製品ポートフォリオ分析
  • セグメント別シェア分析
  • 収益の前年比比較（2021-2023）

主要企業プロファイル

• Pfizer Inc.（USA）
• AbbVie Inc.（USA）
• Johnson & Johnson（USA）
• Eli Lilly and Company（USA）
• Novartis AG（Switzerland）
• Bayer AG（Germany）
• Teva Pharmaceutical Industries Ltd.（Israel）
• Merck & Co., Inc.（USA）
• Takeda Pharmaceutical Company Limited（Japan）
• Sanofi（France）
• Chugai Pharmaceutical Co., Ltd.（Japan）
• Seikagaku Corporation（Japan）
• Anika Therapeutics, Inc.（USA）
• Ferring B.V.（Netherlands）
• Bioventus（USA）
• Flexion Therapeutics, Inc.（USA）
• Zimmer Biomet Holdings, Inc.（USA）
• Smith & Nephew plc（UK）
• Medtronic plc（Ireland）
• Stryker Corporation（USA）

結論と推奨事項

Global Joint Pain Injections Market size was valued at USD 6.3 billion in 2022 and is poised to grow from USD 6.79 billion in 2023 to USD 12.28 billion by 2031, growing at a CAGR of 7.7% during the forecast period (2024-2031).

The global Joint Pain Injections market is poised for substantial growth, fueled by a rising incidence of joint disorders, an aging population, and an escalating demand for minimally invasive treatments. These injections not only deliver targeted pain relief but also enhance joint functionality, serving as a preferable alternative to surgery. Innovations in injection technologies and novel formulations aimed at improving efficacy and longevity are further propelling market expansion. The increasing acceptance of regenerative medicine and biologic injection therapies is also transforming the market dynamics. Nonetheless, challenges such as high costs, limited reimbursement options, and potential side effects could impede future growth prospects. Overall, this sector presents significant opportunities driven by evolving patient needs and technological advancements.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Joint Pain Injections market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Joint Pain Injections Market Segmental Analysis

Global Joint Pain Injections Market is segmented by type, joint, end use and region. Based on type, the market is segmented into hyaluronic acid injections, corticosteroid injections, platelet rich plasma injections and others. Based on joint, the market is segmented into knee, shoulder & elbow, ankle & hip and other joint types. Based on end use, the market is segmented into hospitals, clinics and other. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Joint Pain Injections Market

A key factor propelling the global Joint Pain Injections market is the rising prevalence of joint-related disorders. The escalating rates of conditions like osteoarthritis and rheumatoid arthritis have led to heightened demand for efficient pain relief treatments, particularly joint pain injections. Additionally, the aging population, coupled with increasingly sedentary lifestyles and the frequency of sports-related injuries, further fuels this market expansion. As more individuals seek effective methods to manage their joint pain, the market for joint pain injections continues to grow, reflecting a significant need for innovative and targeted therapeutic options in the healthcare landscape.

Restraints in the Global Joint Pain Injections Market

One significant restraint on the global Joint Pain Injections market is the elevated cost associated with these treatments. For many individuals, particularly those lacking adequate insurance coverage, the price of joint pain injections can be prohibitively high. This financial barrier restricts access to necessary treatment options for patients, notably in developing regions where healthcare affordability poses a considerable challenge. Furthermore, the reimbursement policies and regulatory obstacles present in certain countries can further impede market expansion, limiting the availability and acceptance of joint pain injections among potential users. Overall, these factors contribute to a constrained market environment.

Market Trends of the Global Joint Pain Injections Market

The global Joint Pain Injections market is witnessing a significant trend towards the adoption of minimally invasive procedures, driven by a burgeoning demand for non-surgical treatment options among patients and healthcare providers. This shift towards injections is fueled by their advantages, such as quicker recovery times, lower complication risks, and reduced postoperative discomfort. Administered in outpatient settings, these injections deliver targeted pain relief directly to the affected joints, enhancing patient comfort and satisfaction. Furthermore, the trend reflects a broader movement towards personalized and patient-centric care, enabling customized treatment plans that cater to individual patient needs and preferences, ultimately fostering a more proactive approach to managing joint pain.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2023
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Joint Pain Injections Market Size by Type & CAGR (2024-2031)

• Market Overview
• Hyaluronic Acid Injections
• Corticosteroid Injections
• Platelet Rich Plasma Injections
• Others

Global Joint Pain Injections Market Size by Joint & CAGR (2024-2031)

• Market Overview
• Knee
• Shoulder & Elbow
• Ankle & Hip
• Other Joint Types

Global Joint Pain Injections Market Size by End Use & CAGR (2024-2031)

• Market Overview
• Hospitals
• Clinics
• Other

Global Joint Pain Injections Market Size & CAGR (2024-2031)

• North America (Type, Joint, End Use)
  • USA
  • Canada
• Europe (Type, Joint, End Use)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, Joint, End Use)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, Joint, End Use)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Joint, End Use)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2023
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• Pfizer Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AbbVie Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eli Lilly and Company (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novartis AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bayer AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teva Pharmaceutical Industries Ltd. (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck & Co., Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Takeda Pharmaceutical Company Limited (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanofi (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Chugai Pharmaceutical Co., Ltd. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Seikagaku Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Anika Therapeutics, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ferring B.V. (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bioventus (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Flexion Therapeutics, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zimmer Biomet Holdings, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Smith & Nephew plc (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stryker Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations